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Introduction
Reactive oxygen species (ROS) comprise oxygen free
radicals, including superoxide anion (O2
-), hydroxyl (HO
•),
peroxy (RO2
•) and alkoxy (RO
•) radicals, and oxygen-
derived non-radical species like hydrogen peroxide (H2O2)
and singlet oxygen (
1O2) 
1, 2. As a consequence of aerobic
metabolism, ROS are continuously generated in biological
systems and simultaneously detoxified by complex antioxi-
dative mechanisms 
3. Oxidative stress develops due to imbal-
ance between the systems that generate and scavenge free
radicals 
4. Persisting oxidative stress leads to the accumula-
tion of oxidative damage of the crucial biomolecules: geno-
mic DNA, lipids and proteins.
Reactive oxygen species in carcinogenesis
Aside from DNA-damaging function, ROS can act as
second messengers and control various signaling cascades
which induce and maintain the oncogenic phenotype of can-
cer cells 
5. The effects of ROS include anticancer activities
(cell cycle arrest, senescence, apoptosis or necrosis, inhibi-
tion of angiogenesis) and pro-cancer activities (promotion of
cell proliferation, invasiveness, angiogenesis, metastases and
apoptosis suppression) 
6.
The incidence of malignant neoplasms increases with
age. Lifelong constant attacks of free radicals are considered
one of the main culprits for this. The average rate of DNA
oxidative products generation is about 1 in 10
5 DNA bases,
but is this enough to cause the spontaneous malignancy re-
lated to age? It was found that free radicals primarily damage
specific genomic sequences that are important for carcino-
genesis 
6, 7. Per example, oxidative DNA damage in gastric
mucosa in patients with Helicobacter pylori infection is un-
evenly distributed among the genes, with a tropism for TP53
gene 
8.
Significant number of enzymatic and non-enzymatic
systems protects the cell from ROS toxicity. Their impair-
ment could also lead to deteriorating effects of ROS. Gluta-
thione (GSH), an important guardian against the oxidative
damage, accumulates abundantly within the mitochondria of
cancer cells 
9. In vivo studies demonstrated that GSH deple-
tion sensitizes tumor cells to oxidative cytolysis 
3, 9. The
study on knockout mice with the deficiency of copper-zinc
superoxide dismutase (SOD), the enzyme which is main in-
tracellular scavenger of superoxide radicals, revealed the in-
creased liver cancer incidence in such animals 
10. Deficiency
of manganese SOD, which is main O2
- cleaner in mitochon-
drial matrix, leads to mice mortality quickly after birth 
11.
The animals that are heterozygotes for manganese SOD sur-
vive, but carry increased risk to develop lymphoma, adeno-
carcinoma and pituitary adenoma 
12.
Radiation induced carcinogenesis is largely based on
generation of very reactive HO
· radical, which interacts with
DNA causing the formation of mutagenic purines, pyri-
midines and oxidative deoxyribose products, such as 8-
hydroxy-2-deoxyguanosine (8OHdG) 
6, 13. The defects in en-
zymes responsible for reparation of oxidative DNA damage
increase the level of 8OHdG and other mutagenic bases,
leading to higher incidence of age-related cancer in animals 
14.
The DNA itself or its precursors can be altered by ROS. In
mice with MTH1 enzyme deficiency, which hydrolyses
DNA precursors damaged by oxidative mechanisms, the in-
corporation of these defective nucleotides in DNA is en-
abled. This increases the rate of spontaneous tumorigenesis
primarily in lungs, stomach and liver 
14, 15.
The role of ROS in apoptosis
It is well-established that mediators of apoptosis can in-
duce intracellular production of ROS. Moreover, various reac-
tive species can either initiate apoptosis or modify its course 
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Apoptosis can be induced by extracellular or intracellular
signals and is conducted through two major pathways: mito-
chondrial (intrinsic) or death receptor pathway (extrinsic). Ex-
trinsic pathway of apoptosis is triggered by interaction of death
receptor and its ligand in cellular plasma membrane 
16, which
activates nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase and generation of ROS. This further leads
to activation of acid sphingomielinase, generation of ceramide
and clustering of the receptors. The described processes form
signal platform that induces apoptotic cascade 
17. Activation of
NF-țB survival path increases the transcription of anti-
apoptotic proteins (FLIP, MnSOD, Bcl-X, IAP) and blocks the
apoptosis. In the presence of high ROS concentrations, the im-
possibility of NF-țB induction triggers the activation of
ASK1/JNK kinases, which initiates apoptosis 
18.
Intrinsic apoptotic cascade is associated with the
changes in permeability of outer mitochondrial membrane,
which allows the release of proapototic proteins. ROS are
well known triggers of intrinsic apoptotic pathway through
interaction with outer mitochondrial membrane proteins 
19.
Proteins of the Bcl-2 family determine the susceptibility to
apoptosis, shifting the balance between pro-apoptotic (Bax,
Bak, Bad, Bim and Bid) and anti-apoptotic (Bcl-2, Bcl-XL
and Bcl-w) members of the family in favour of apoptosis or
against it. In the presence of apoptotic stimuli like ROS,
truncated form of Bid protein causes Bax/Bak oligomeriza-
tion which leads to creation of megapores in mitochondrial
membrane 
20. Subsequently, apoptosome complex is formed
in the cytosol, activating initiator Caspase 9 and than
Caspase 3, which executes the final steps of apoptosis.
Caspase activation is further enhanced due to neutralization
of caspase inhibitors by proteins released from mitochondria,
like Smac/Diablo and Omi/HtrA2 
19. In addition, mitochon-
drial proteins like apoptesis-inducing factor and Endo G
stimulate caspase-independent apoptosis via translocation
into nucleus, where they mediate genomic DNA fragmenta-
tion 
21.
Programmed cell death is often characterized by gen-
eration of large quantities of ROS or transient oxidative
burst 
22. Catalase prevents H2O2 mediated apoptosis, indi-
cating the important role of H2O2 in apoptosis 
2. Recently it
has been found that H2O2 initiates caspase activation which
is dependant on mitochondrial cytochrome c release 
23. How-
ever, very high doses of H2O2 or other ROS induce cell ne-
crosis 
13, 23. This implies that the modus of cell death induced
by oxidative stress is dose dependant. Since apoptosis repre-
sents active, energy dependant process, it seems that the in-
tracellular ATP level is crucial determinant weather the
apoptotic cascade would eventuate.
The interplay of ROS and apoptosis in cancer
Although apoptosis and cancer represent opposite enti-
ties, ROS play an important role in both of the processes.
Moderate levels of ROS, where “moderate” depends on the
cell type, promote apoptosis in tumor cells 
24. Nevertheless,
in some malignant cells ROS can exert the opposite effect. In
melanoma cell line M14, overexpression of zinc-copper SOD
causes the decrease in O2
- concentration and thus promotes
apoptosis 
25. Generation of ROS by NADPH oxidase enzy-
matic system acts as an anti-apoptotic, pro-proliferative
stimulus in pancreatic cancer cell lines 
26. The ability of mi-
tochondrial apoptosis-inducing factor to oxidase NADH and
generate superoxide anion contributes to viability of some
cancer cell lines 
27.
The mechanisms by which ROS exert their anti-
apoptotic effect have not been completely elucidated so far.
It has been hypothesized that caspase inactivation could be
responsible. In some cells elevated O2
- causes the increase in
cytosolic pH value, which halts the caspase activation 
28. In
opposite, H2O2 lowers pH in cytosol and thus acts in favor of
apoptosis initiation. In addition, H2O2 promotes apoptosis
through conversion in HO
· radical that directly attacks DNA
or damages mitochondria 
28. An alternative mechanism in-
cludes inactivation of PTEN protein (product of tumor sup-
pressor gene PTEN), which increases the activation of Akt
signaling pathway, thus promoting cell survival. However,
Akt signaling is often attributed ambiguous roles, since some
studies have indicated that the activation of this path sup-
ports cancer cell survival, but suppresses invasiveness and
metastases 
29.
The phenomenon of apoptosis has been investigated in
many types of cancer and its significance has been well-
established for urothelial carcinoma 
30–32. Recent findings
have suggested that oxidative stress sensitizes tumor cells to
tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL)-mediated apoptosis by downregulation of anti-
apoptotic proteins 
33. Moreover, TRAIL protein has gained a
lot of attention as a new therapeutic target because of its
property to induce apoptosis only in cancer cells, but not in
normal cells 
34. However, some urothelial carcinomas de-
velop resistance to TRAIL, therefore the reestablishment of
this sensitivity is of great importance. Induction of oxidative
stress with low concentration of H2O2 can reverse the resis-
tance to TRAIL by significantly decreasing the expression of
short living anti-apoptotic proteins such as FLIP, XIAP and
Survivin 
33. Further studies are to determine the relevancy of
H2O2 application as adjuvant intravesical agent in urothelial
cancer treatment, in order to lower the threshold for initiating
apoptosis in malignant cells.
Apoptosis induced by ROS in anticancer treatment
Numerous studies confirmed that generation of free
radicals capable of inducing apoptosis in malignant cells is
the underlying mechanism of action for numerous chemo-
therapeutics and radiotherapy 
3, 35, 36. Antineoplastic agents
that induce generation of ROS in large quantities are anthra-
cyclines (doxorubicin, bleomycin), platinum complexes (cis-
platin), alkylating agents (cyclophosphamide), epipodophyl-
lotoxins, camptothecin derivatives 
37. In the course of radio-
therapy of malignant disease, apoptotic signal can be gener-
ated in plasma membrane through lipid peroxidation induced
by radiation 
13. Antioxidants reduce ROS generation and thus
contribute to preserve the integrity of healthy tissue, but also
decrease the damage on tumor cells 
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ROS generating anticancer drugs lead to depletion of
intracellular antioxidative capacity and when the ROS
concentration reaches a certain threshold, apoptosis is
initiated 
13. In the absence of adequate antioxidative de-
fense, damage caused by ROS induces activation of apopto-
sis-related genes. In addition, intracellular ROS increase can
also activate redox sensitive JNK/SAPK signaling pathway,
often implicated in genes transactivation and posttransla-
tional modifications of proteins required for apoptosis 
23.
Future implications
Pharmacological manipulations are able to shift the in-
tracellular redox equilibrium toward the increase in ROS
and/or the depletion of protective agents, inducing the apop-
totic cascade in cancer cell. The studies investigating appli-
cation of antioxidant inhibitors and/or ROS generating
agents in order to induce apoptosis or to overcome the resis-
tance to chemotherapy 
39, 40 have provided significant ad-
vances, but further validation of the results is necessary.
Genomics and proteomics represent powerful and
promising tools in unraveling complex molecular net-
works 
41, 42. Investigators have attempted to understand the
subset of proteins whose expression levels are directly al-
tered by oxidants, or those proteins that are posttranslation-
ally modified in a redox-dependent fashion 
43. Recent pro-
teomics based study identified gold (III) porphyrin 1a as a
new, potent anticancer drug that induces apoptosis through
both caspase-dependent and caspase-independent mito-
chondrial pathways, and demonstrated that intracellular
oxidation affected gold (III) porphyrin 1a-induced apopto-
sis 
44. The difficulty with advanced “omics” methodologies
is how to translate the provided data into a meaningful
clinical context, ie into clinical trial design and subse-
quently into routine clinical use 
41.
One of the most important goals in cancer studies is di-
rected to the possibility of treating cancer by inducing apop-
tosis via caspase activation. ROS could play a major role in
this process, acting as potent mediators. The greatest chal-
lenge remains the issue of inducing apoptosis selectively
within the neoplastic cells, with maximal spearing of normal
tissue. The therapeutic strategy based on triggering apoptosis
by modulation of ROS levels, selectively within the neoplas-
tic cells, carries great expectations and holds promise of a
significant advance in clinical oncology.
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